References
- Kalarus Z, Svendsen JH, Capodanno D, et al. Cardiac arrhythmias in the
emergency settings of acute coronary syndrome and revascularization:
an European Heart Rhytm Association (EHRA) consensus document,
endorsed by the European Association of Percutaneous Cardiovascular
Interventions (EAPCI), and European Acute Cardiovascular Care
Association (ACCA). Europace. 2019;21:1603-1604.
- Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the
management of acute myocardial infarction in patients presenting with
ST-segment elevation: The task Force for the management of acute
myocardial infarction in patients presenting with ST-segment elevation
of the European Society of Cardiology (ESC). Eur Heart J .
2018;39:119-177.
- Kober L, Swedberg K, McMurray JJ, et al. Previously known and newly
diagnosed atrial fibrillation: a major risk indicator after a
myocardial infarction complicated by heart failure or left ventricular
dysfunction. Eur J Heart Fail. 2006;8:591-598.
- Türk UÖ, Zoghi M, Alioğlu E, Ergene O. Rationale and design of the
myocardial infarction with non-obstructive coronary arteries in
Turkish population (MINOCA-TR) study. Turk Kardiyol Dern Ars .
2019;47:662-668.
- Yasuda S, Kaikita K, Akao M, et al; AFIRE Investigators.
Antithrombotic therapy for atrial fibrillation with stable coronary
disease. N Engl J Med. 2019;381:1103-1113.
- Banach M, Rysz J, Drozdz JA, et al. Risk factors of atrial
fibrillation following coronary artery bypass grafting: A preliminary
report. Circ J. 2006;70:438-441.
- Rathore SS, Berger AK, Weinfurt KP, et al. Acute myocardial infarction
complicated by atrial fibrillation in the elderly: prevalence and
outcomes. Circulation. 2000;101:969-974.
- Yavuz B, Ata N, Oto E, et al. Demographics, treatment and outcomes of
atrial fibrillation in a developing country: the population-based
TuRkish Atrial Fibrillation (TRAF) cohort. Europace.2017;19:734-740.
- Ertaş FS, Tokgözoğlu L; EPICOR Study Group. Pre- and in-hospital
antithrombotic management patterns and in-hospital outcomes in
patients with acute coronary syndrome: data from the Turkish arm of
the EPICOR study. Anatol J Cardiol. 2016;16:900-915.
- Awad HH, Zubaid M, Alsheikh-Ali AA, et al. Comparison of
characteristics, management practices, and outcomes of patients
between the global registry and the gulf registry of acute coronary
events. Am J Cardiol. 2011;108:1252-1258.
- Mohamed MO, Kirchhof P, Vidovich M, et al. Effect of concomitant
atrial fibrillation on in-hospital outcomes of non-ST-elevation acute
coronary syndrome-related hospitalizations in the United States.Am J Cardiol. 2019;124:465-475.
- Mehta LS, Beckie TM, DeVon HA, et al. Acute myocardial infarction in
women: a scientific statement from the American Heart Association.Circulation. 2016;133:916-947.
- Kilic D, Ozturk S. Gender differences in cigarette consumption in
Turkey: evidence from the Global Adult Tobacco Survey. Health
Policy. 2014;114:207-214.
- Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillation and
arterial hypertension. Pharmacol Res. 2018;128:322-326.
- Namana V, Gupta SS, Sabharwal N, Hollander G. Clinical significance of
atrial kick. QJM. 2018;111:569-570.
- Saito Y, Kobayashi Y. Triple therapy: A review of antithrombotic
treatment for patients with atrial fibrillation undergoing
percutaneous coronary intervention. J Cardiol. 2019;73:1-6.
- Lopes RD, Hong H, Harskamp RE, et al. Optimal antithrombotic regimens
for patients with atrial fibrillation undergoing percutaneous coronary
intervention: an updated network meta-analysis. JAMA Cardiol.2020;5:1-8.
- January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update
of the 2014 AHA/ACC/HRS guideline for the management of patients with
atrial fibrillation: A report of the American College of
Cardiology/American Heart Association task force on clinical practice
guidelines and the Heart Rhythm Society in collaboration with the
Society of Thoracic Surgeons. Circulation. 2019;140:e125-e151.
- Steffel J, Verhamme P, Potpara TS, et al; ESC Scientific Document
Group. The 2018 European Heart Rhythm Association practical guide on
the use of non-vitamin K antagonist oral anticoagulants in patients
with atrial fibrillation. Eur Heart J. 2018;39:1330-1393.
Table-1: Demographic and clinical characteristics of study
population at admission.